In2Bones SAS Sustainability Profile
In2Bones SAS, headquartered in France, is a leading innovator in the orthopaedic and trauma device industry. Founded in 2009, the company has established a strong presence across Europe and North America, focusing on advanced solutions for bone fixation and surgical procedures. In2Bones is renowned for its unique range of products, including innovative plates, screws, and surgical instruments designed to enhance patient outcomes and streamline surgical workflows. The company’s commitment to research and development has positioned it as a key player in the market, with notable achievements in product efficacy and safety. With a focus on quality and innovation, In2Bones SAS continues to set benchmarks in the orthopaedic sector, making significant strides in improving surgical techniques and patient care.
DitchCarbon Score
How does In2Bones SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
In2Bones SAS's score of 28 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
In2Bones SAS, headquartered in France, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of CONMED Corporation, which may influence its climate commitments and emissions reporting. As of now, In2Bones SAS has not established any documented reduction targets or climate pledges. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given its affiliation with CONMED Corporation, it is possible that emissions data and climate commitments could be inherited or influenced by the parent company's sustainability initiatives. However, without explicit data or targets from either In2Bones SAS or CONMED Corporation, it is challenging to provide a detailed overview of their carbon footprint or climate action plans. In summary, while In2Bones SAS is part of a larger corporate family, it currently lacks specific emissions data and defined climate commitments, indicating a potential area for future development in sustainability practices.
How Carbon Intensive is In2Bones SAS's Industry?
How Carbon Intensive is In2Bones SAS's Location?
In2Bones SAS's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
In2Bones SAS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
